← Back to Search

Quantitated Blood Volume Analysis for Heart Failure

N/A
Waitlist Available
Led By Wayne Miller, MD, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 month, 3 month, and 6 month
Awards & highlights

Study Summary

This trial is testing whether measuring blood volume may help researchers develop better ways of treating and managing heart failure patients.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 month, 3 month, and 6 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 month, 3 month, and 6 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in plasma volume
Change in red blood cell volume
Change in total blood volume

Trial Design

1Treatment groups
Experimental Treatment
Group I: Subjects with heart failureExperimental Treatment1 Intervention
Subjects admitted to the hospital for acute decompensation of chronic systolic heart failure will have a Quantitated Blood Volume Analysis blood test done
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Quantitated Blood Volume Analysis
2020
N/A
~20

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,204 Previous Clinical Trials
3,768,083 Total Patients Enrolled
72 Trials studying Heart Failure
1,022,013 Patients Enrolled for Heart Failure
Wayne Miller, MD, PhDPrincipal InvestigatorMayo Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are we currently accepting participants for this research project?

"No, this particular clinical trial is not presently looking for patients. The clinical trial was initially posted on 1/30/2020 and was last updated on 9/29/2022. Although this clinical trial is not seeking patients anymore, there are 731 other studies currently accepting participants at this time."

Answered by AI
Recent research and studies
Annals of Internal MedicineJournal
Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate
Levey, Andrew S., Josef Coresh, Tom Greene, Lesley A. Stevens, Yaping (Lucy) Zhang, Stephen Hendriksen, John W. Kusek, and Frederick Van Lente. 2006. “Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate”. Annals of Internal Medicine. American College of Physicians. doi:10.7326/0003-4819-145-4-200608150-00004.
clinicaltrials.govStudy
Intravascular Volume Expansion to Neuroendocrine-Renal Function Profiles in Chronic Heart Failure
Wayne L. Miller, M.D., Ph.D. 2020. "Intravascular Volume Expansion to Neuroendocrine-Renal Function Profiles in Chronic Heart Failure". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04156854.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top